Skip to content
Sword Bio logo
  • Services
    • Bioanalytical Services
    • Custom Biomarkers
    • MSD Assays
    • Pharmacokinetics (PK)
    • Immunogenicity
    • Modalities
      • Antibody Therapeutics
      • Cell & Gene Therapy
    • Complementary Services
      • Molecular
      • Sword High Sensitivity
  • Resources
    • Blog
    • Press
    • Video
    • Case Study
  • Our Team
  • Contact
  • Search

Month: September 2023

ADA Assays Screening Viral Vectors For Gene Therapy

By Sword Bio | September 8, 2023
ADA Assays Screening Viral Vectors for Gene Therapy

By integrating modified or new genes into the cells of the human body, gene therapy has the potential to treat a wide variety of acquired and inherited diseases. Genetic therapeutics must deliver the intended genetic material to a large quantity of specific cells within the correct tissue. Properly targeting cells requires that the genetic material…

Read More...

Recent Posts

  • Five Recurring Deficiencies in Biologic Assay Submissions
  • Validating Bioanalytical Assays Under ICH M10
  • From Biologics to Gene Therapy: A Conversation with Jim McNally
  • How CRO Partnerships Accelerate Biologic Drug Development
  • Bioanalytical Challenges in Cell and Gene Therapy Products

Categories

  • Assay Development
  • Blog
  • Case Study
  • Company Update
  • Press Release

Archives

  • July 2026
  • May 2026
  • March 2026
  • February 2026
  • December 2025
  • November 2025
  • September 2025
  • July 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • April 2024
  • September 2023
  • August 2023
  • July 2023
  • May 2023
  • April 2023
Sword Bio logo
  • 866.907.9673
  • info@swordbio.com
  • Sword Bio Offices
    13295 Illinois Street, Suite 103
    Carmel, IN 46032
  • Sword Bio Labs
    2255 W. Harrison St., Suite A
    Chicago, IL 60612
  • Sitemap

Copyright © 2026 Sword Bio

Limited Use Label License